Aurora collaborates to win another patient support award, helping the one million people who live with heart failure

by Nathan McGlone . November 2021

Last week’s highly regarded Pharmaceutical Market Excellence Awards (PMEAs) featured incredible examples of the impact we can make to the lives of patients, families and healthcare professionals. Congratulations to all the winners and nominees.

We are thrilled to have been there and to have brought home the award for Excellence in Patient Education and Support collaborating with Novartis, The Clarion Portfolio and Salt.

Fighting Failure: Reprioritising Heart Failure Care in the UK

Heart failure (HF) is a condition that is becoming increasingly prevalent but is poorly recognised. Almost 1 million people in the UK are currently living with HF, with a further 200,000 new patients diagnosed each year.

With a disparity of care across the country, we had to act and create a campaign that would increase the level of understanding of HF in the UK and drive improved diagnosis, care and quality of life for patients. In-depth research and insights gathering confirmed that there was a significant challenge ahead of us. We needed to create a campaign to drive change in HF, but we knew we could not do this alone.

Collaborating closely with healthcare professionals and patients was key and the only path that could make a difference. With partnership at the heart of the campaign, the strategic direction became clear. By the people, for the people.

The Fighting Failure campaign has created practical resources for the HF community and a spirit to help motivate those living with the disease to seek improvement in their quality of life.

As the judges’ commented: “It had bold ambition across UK stakeholders and focused on the need for information. Exceeded expectations.”

If you would like to find out more about our award-winning work to support patients, please get in touch.